Healthcare

Rapid technological turnaround has become a norm in the life science and in-vitro diagnostic industry. Extrinsic factors such as lack of skilled labor to operate the instrumentation as well as functional factors like demand for very high precision and reproducibility of results are driving this technological evolution. As the instrument efficiency ...

How can a technology company used to delivering products and services to consumers and industry find success in healthcare? Information communication technology (ICT) firms often fail when bringing new offerings to the healthcare market; a market that represents $115 billion in potential revenue for technology solutions. To answer this question, ...

Healthcare today is not about just going to the doctor at the time of illness or on regular appointments to check the overall disease progression. It is shifting to a more proactive rather than reactive approach with patients being more aware and willing to be involved in their own health. The traditional culture of healthcare and how people engage...

The CHC18 marked the tenth year of this event that is now co-produced by the Personal Connected Health Alliance (PCHA), a HIMSS organization, and Partners HealthCare of Boston. This event has grown from the 1st edition that attracted 750 attendees to this latest edition that included 300 speakers. We were told, unofficially, that the attendance fo...

The impressive advances in life sciences research and development (R&D) befallen in the past two-three years are playing a leading role in the transformation of the healthcare industry. A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approach...

Both predictive and prognostic biomarkers constitutes an central element in each and every targeted oncology drug discovery and development program. Breakthrough technologies allowing leveraging biomarkers for oncology are paving the way of personalized medicine and precision oncology. Indeed, oncology biomarkers provide the clinical community with...

Healthcare expenditure in Singapore is expected to grow, fueled by factors such as rising incomes and a progressively aging population. Diagnostics has emerged as a way for earlier and better identification of diseases to control rising healthcare costs in Singapore. Hence, the country has become a natural choice for many global diagnostic companie...

Frost & Sullivan announces exciting new research from its Transformational Health program touching on some of the most important issues in healthcare now and in the future. This Frost & Sullivan research service presents a comprehensive analysis of the market potential and dynamics of the population health management (PHM) market in the United S...

A Frost & Sullivan perspective of the German Bone Mineral Density Solutions and Regulatory Trends has been covered in this research, which highlights on: • Product Registration & CE Approval Process in Germany • Regulatory Requirements for Product Registration for DEXA-BMD device in Germany • Phantom Testing – Calibrations and Quali...